header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

ESTABLISHED TIBIAL NON-UNION TREATED WITH ONE STAGE DISTRACTION OSTEOGENESIS



Abstract

Introduction: Sequential staged distraction with fixed rate and rhythm, alternative compression and distraction is well described in the literature to treat non-unions. However we looked the union in established non-unions of tibia using one stage distraction without further manipulation at the fracture site maintaining the stability.

Materials and Methods: 12 patients with established tibial non-unions were referred during the period of 2001–2005. 2 cases were infected non unions. All patients were symptomatic and exhibited deformity at the non-union site. Ten males, two females were in the study group with a mean age of 39.2 years. The location of non-union was distal 1/3 of tibia in 8 cases and 2 cases of proximal and middle 1/3. External fixation was used to acutely distract the fracture (one stage) and tension the soft tissues to attain fracture stability. Infection at the fracture site required further operative debridement. Regular followup with radiographs to assess the union.

Results: Osseous union was achieved in all the cases at an average time period of 17.2 weeks. There was no recurrence of osteomyelitis in the infected cases following secondary debridement. All the patients were pain free and fully mobile without aid at review.

Conclusion: We concluded that acute distraction osteogenesis produces fracture union in selected established cases of non union. This method can be used to obtain impressive gains in the lengths of the long bones. Bone is uniformly produced regardless of the location of the non union. This is more patient compliant, effective and relatively easy to perform.

Correspondence should be addressed to Ms Larissa Welti, Scientific Secretary, EFORT Central Office, Technoparkstrasse 1, CH-8005 Zürich, Switzerland